UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 607/2025

Jul 8, 2025·EP4241767 Unitary patent · NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Follow
Case details
Status
Case Closed
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties
Claimants
Representatives
Respondents
Representatives
Division
The Hague LD
Judges
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
  • ModernaTX, Inc.Withdrawn2025-04-29
  • Merck Sharp & Dohme (UK) LimitedWithdrawn2025-07-23
  • Arrowhouse GmbHAdmissible2025-07-23
  • Keltie LLPAdmissible2025-07-23
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
The Hague LDLockedLocked
Judge Edger BrinkmanLockedLocked
Judge Margot KokkeLockedLocked
Judge Samuel GranataLockedLocked
Judge Xavier Dorland-GalliotLockedLocked

At the UPC: Moderna Group (20 cases)·Arbutus Biopharma Corporation (12 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 3 other proceedings

UPC APP 18039/2025·UPC APP 25212/2025·UPC APP 27016/2025

3 other defendants litigating the same or a related patent

UPC CFI 2562/2026·UPC CFI 2566/2026·UPC CFI 192/2025

Start a free trial to see how each one ended.

More cases: The Hague LD·2025

Documents
Document titleDatePublic
Case closed2026-08-25Not public
Order2026-08-25Not public
Order2026-08-25Not public
Hearing recording reference document2026-03-09Not public
Receipt2026-03-04Not public
Cover sheet2026-03-04Not public
Application document Defendant2026-03-04Not public
Receipt2026-02-27Not public
Cover sheet2026-02-27Not public
Document Claimant2026-02-27Not public
Communication2026-02-27Not public
Receipt2026-02-26Not public
Cover sheet2026-02-26Not public
Fee2026-02-26Not public
Application document Claimant2026-02-26Not public
Receipt2026-02-19Not public
Cover sheet2026-02-19Not public
Exhibit Claimant2026-02-19Not public
Exhibit Claimant2026-02-19Not public
Order2026-02-12Not public
Order2026-02-12Public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Defendant2026-01-21Not public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Defendant2026-01-21Not public
Interim procedure opened2026-01-14Not public
Written procedure closed2026-01-14Not public
Receipt2026-01-12Not public
Cover sheet2026-01-12Not public
Statement of rejoinder2026-01-12Not public
Exhibit document Defendant2026-01-12Not public
Exhibit document Defendant2026-01-12Not public
Exhibit document Defendant2026-01-12Not public
Order2025-12-23Not public
Order2025-12-23Not public
Cover sheet2025-12-18Not public
Further pleadings2025-12-18Not public
Receipt2025-12-18Not public
Cover sheet2025-12-16Not public
Exhibit document Defendant2025-12-16Not public
Exhibit document Defendant2025-12-16Not public
Receipt2025-12-16Not public
Communication2025-12-16Not public
Cover sheet2025-12-15Not public
Further pleadings2025-12-15Not public
Receipt2025-12-15Not public
Communication2025-12-11Not public
Cover sheet2025-12-10Not public
Exhibit document Defendant2025-12-10Not public
Exhibit document Defendant2025-12-10Not public
Exhibit document Defendant2025-12-10Not public
Counterclaim rejoinder2025-12-10Not public
Receipt2025-12-10Not public
Cover sheet2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Counterclaim reply2025-11-10Not public
Application to Amend Patent Defence2025-11-10Not public
Receipt2025-11-10Not public
Panel-Appointment2025-09-17Not public
Acknowledgement-of-lodging2025-09-11Not public
Formal-checks_Notification-of-positive-outcome2025-09-11Not public
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio2025-09-10Not public
Exhibit A091 - EP 767 Claim requests (clean version)2025-09-10Not public
Exhibit A102 - US 61/242,761 - FBD-T 63 P32025-09-10Not public
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis2025-09-10Not public
Exhibit A106 - US 61/222,464 - FBD-T 67 P12025-09-10Not public
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration2025-09-10Not public
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharm2025-09-10Not public
Exhibit A118 - Moderna IT webpage2025-09-10Not public
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)2025-09-10Not public
Exhibit A116 - Moderna ES supply invoicing EU states2025-09-10Not public
Exhibit A101 - US 61/234,045 - FBD-T 63 P22025-09-10Not public
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o2025-09-10Not public
Exhibit A115 - Arbutus Genevant CLA 2018 SEC2025-09-10Not public
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid2025-09-10Not public
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery2025-09-10Not public
Exhibit A092 - EP 767 Claim requests (tracked changes version)2025-09-10Not public
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery2025-09-10Not public
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids2025-09-10Not public
Exhibit A108 - US 61/231,579 - FBD-T 62 P22025-09-10Not public
Exhibit A103 - US 61/251,999 - FBD-T 63 P42025-09-10Not public
Exhibit A100 - US 61/175,777 - FBD-T 63 P12025-09-10Not public
Exhibit A107 - US 61/159,788 - FBD-T 62 P12025-09-10Not public
Reply to SoD + Defence to CC + App to Amend2025-09-10Not public
Exhibit A094 - Jeffs 2005 - A Scalable Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA2025-09-10Not public
Exhibit A099 - Register extract of FBD-T 662025-09-10Not public
Exhibit A105 - US 61/222/469 - FBD-T 65 P12025-09-10Not public
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information2025-09-10Not public
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain, Moderna Switzerland and Moderna Netherlan2025-09-10Not public
Exhibit A104 - US 61/258,848 - FBD-T 63 P52025-09-10Not public
Formal-checks_Notification-of-positive-outcome2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration2025-09-10Not public
Exhibit A091 - EP 767 Claim requests (clean version)2025-09-10Not public
Exhibit A103 - US 61-251.999 - FBD-T 63 P42025-09-10Not public
Exhibit A092 - EP 767 Claim requests (tracked changes version)2025-09-10Not public
Exhibit A102 - US 61-242.761 - FBD-T 63 P32025-09-10Not public
Reply to SoD + Defence to CC + App to Amend2025-09-10Not public
Exhibit A094 - Jeffs 2005 - A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA2025-09-10Not public
Exhibit A104 - US 61-258.848 - FBD-T 63 P52025-09-10Not public
Exhibit A100 - US 61-175.777 - FBD-T 63 P12025-09-10Not public
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)2025-09-10Not public
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery - improved endosomal escape and sustained phar2025-09-10Not public
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio2025-09-10Not public
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery2025-09-10Not public
Exhibit A107 - US 61-159.788 - FBD-T 62 P12025-09-10Not public
Exhibit A101 - US 61-234.045 - FBD-T 63 P22025-09-10Not public
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis2025-09-10Not public
Exhibit A099 - Register extract of FBD-T 662025-09-10Not public
Exhibit A105 - US 61-222.469 - FBD-T 65 P12025-09-10Not public
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery2025-09-10Not public
Exhibit A106 - US 61-222.464 - FBD-T 67 P12025-09-10Not public
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information2025-09-10Not public
Exhibit A115 - Arbutus - Genevant Cross-License Agreement 2018 (SEC version)2025-09-10Not public
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids2025-09-10Not public
Exhibit A116 - Moderna Biotech Spain documentation of Spikevax supply and invoicing to EU states2025-09-10Not public
Exhibit A118 - Moderna Italy webpage2025-09-10Not public
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o2025-09-10Not public
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid2025-09-10Not public
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain - Moderna Switzerland and Moderna Netherla2025-09-10Not public
Exhibit A108 - US 61-231.579 - FBD-T 62 P22025-09-10Not public
Acknowledgement of access to case2025-07-29Not public
Notification Of Service2025-07-29Not public
EPO_Communication_check_Outcome2025-07-25Not public
EPO_Communication_check_Outcome2025-07-23Not public
EPO_Communication_check_Outcome2025-07-23Not public
EPO_Communication_check_Outcome2025-07-23Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-21Not public
Panel-Appointment2025-07-17Not public
EPO-Request-for-case-pending2025-07-17Not public
Acknowledgement-of-lodging2025-07-17Not public
Formal-checks_Notification-of-positive-outcome2025-07-17Not public
Exhibit FBD-T 702025-07-17Not public
Exhibit FBD-T 182025-07-17Not public
Exhibit FBD-T 272025-07-17Not public
Exhibit FBD-T 462025-07-17Not public
Exhibit FBD-T 602025-07-17Not public
Exhibit FBD-T 302025-07-17Not public
Exhibit FBD-T 62025-07-17Not public
Exhibit FBD-T 392025-07-17Not public
Exhibit FBD-T 112025-07-17Not public
Exhibit FBD-T 202025-07-17Not public
Exhibit FBD-T 72025-07-17Not public
Exhibit FBD-T 192025-07-17Not public
Exhibit FBD-T 442025-07-17Not public
Exhibit FBD-T 282025-07-17Not public
Exhibit FBD-T 212025-07-17Not public
2025-07-08_-_UPC2_EP767_Moderna_Statement_of_Defence_and_Counterclaim_for_Revocation2025-07-17Not public
Exhibit FBD-T 252025-07-17Not public
Exhibit FBD-T 372025-07-17Not public
Exhibit FBD-T 102025-07-17Not public
Exhibit FBD-T 482025-07-17Not public
Exhibit FBD-T 572025-07-17Not public
Exhibit FBD-T 642025-07-17Not public
Exhibit FBD-T 652025-07-17Not public
Exhibit FBD-T 242025-07-17Not public
Exhibit FBD-T 172025-07-17Not public
Exhibit FBD-T 422025-07-17Not public
Exhibit FBD-T 512025-07-17Not public
Exhibit FBD-T 292025-07-17Not public
Exhibit FBD-T 522025-07-17Not public
Exhibit FBD-T 672025-07-17Not public
Exhibit FBD-T 162025-07-17Not public
Exhibit FBD-T 52025-07-17Not public
Exhibit FBD-T 382025-07-17Not public
Exhibit FBD-T 262025-07-17Not public
Exhibit FBD-T 32025-07-17Not public
Exhibit FBD-T 612025-07-17Not public
Exhibit FBD-T 22025-07-17Not public
Exhibit FBD-T 152025-07-17Not public
Exhibit FBD-T 622025-07-17Not public
Exhibit FBD-T 122025-07-17Not public
Exhibit FBD-T 42025-07-17Not public
Exhibit FBD-T 402025-07-17Not public
Exhibit FBD-T 532025-07-17Not public
Exhibit FBD-T 352025-07-17Not public
Exhibit FBD-T 682025-07-17Not public
Exhibit FBD-T 342025-07-17Not public
Exhibit FBD-T 502025-07-17Not public
Exhibit FBD-T 582025-07-17Not public
Exhibit FBD-T 332025-07-17Not public
Exhibit FBD-T 82025-07-17Not public
Exhibit FBD-T 692025-07-17Not public
Exhibit FBD-T 412025-07-17Not public
Exhibit FBD-T 452025-07-17Not public
Exhibit FBD-T 362025-07-17Not public
Exhibit FBD-T 322025-07-17Not public
Exhibit FBD-T 562025-07-17Not public
Exhibit FBD-T 12025-07-17Not public
Exhibit FBD-T 472025-07-17Not public
Exhibit FBD-T 312025-07-17Not public
Exhibit FBD-T 552025-07-17Not public
Exhibit FBD-T 592025-07-17Not public
Exhibit FBD-T 492025-07-17Not public
Exhibit FBD-T 662025-07-17Not public
Exhibit FBD-T 132025-07-17Not public
Exhibit FBD-T 542025-07-17Not public
Exhibit FBD-T 432025-07-17Not public
25-07-17_-_Moderna_vs_Genevant_Arbutus_-_EP767_-_Formal_response_to_request_for_amendments_-_CC_318331_20252025-07-17Not public
Exhibit FBD-T 232025-07-17Not public
Exhibit FBD-T 142025-07-17Not public
Exhibit FBD-T 222025-07-17Not public
Exhibit FBD-T 92025-07-17Not public
Exhibit FBD-T 632025-07-17Not public
Formal-checks_Request-for-correction2025-07-10Not public
Exhibit FBD-T 462025-07-08Not public
Exhibit FBD-T 312025-07-08Not public
Exhibit FBD-T 592025-07-08Not public
Exhibit FBD-T 372025-07-08Not public
Exhibit FBD-T 222025-07-08Not public
Exhibit FBD-T 662025-07-08Not public
Exhibit FBD-T 442025-07-08Not public
Exhibit FBD-T 122025-07-08Not public
Exhibit FBD-T 542025-07-08Not public
Exhibit FBD-T 22025-07-08Not public
Exhibit FBD-T 72025-07-08Not public
Exhibit FBD-T 432025-07-08Not public
Exhibit FBD-T 92025-07-08Not public
Exhibit FBD-T 32025-07-08Not public
Exhibit FBD-T 642025-07-08Not public
Exhibit FBD-T 182025-07-08Not public
Exhibit FBD-T 392025-07-08Not public
Exhibit FBD-T 692025-07-08Not public
Exhibit FBD-T 382025-07-08Not public
Exhibit FBD-T 582025-07-08Not public
Exhibit FBD-T 342025-07-08Not public
Exhibit FBD-T 682025-07-08Not public
Exhibit FBD-T 472025-07-08Not public
Exhibit FBD-T 292025-07-08Not public
Exhibit FBD-T 412025-07-08Not public
Exhibit FBD-T 502025-07-08Not public
Exhibit FBD-T 212025-07-08Not public
Exhibit FBD-T 562025-07-08Not public
Exhibit FBD-T 272025-07-08Not public
Exhibit FBD-T 242025-07-08Not public
Exhibit FBD-T 62025-07-08Not public
Exhibit FBD-T 422025-07-08Not public
Exhibit FBD-T 262025-07-08Not public
Exhibit FBD-T 352025-07-08Not public
Exhibit FBD-T 152025-07-08Not public
Exhibit FBD-T 652025-07-08Not public
Exhibit FBD-T 482025-07-08Not public
Exhibit FBD-T 202025-07-08Not public
Exhibit FBD-T 402025-07-08Not public
Exhibit FBD-T 362025-07-08Not public
Exhibit FBD-T 622025-07-08Not public
Exhibit FBD-T 232025-07-08Not public
Exhibit FBD-T 102025-07-08Not public
Exhibit FBD-T 522025-07-08Not public
Exhibit FBD-T 512025-07-08Not public
Exhibit FBD-T 702025-07-08Not public
Exhibit FBD-T 322025-07-08Not public
Exhibit FBD-T 82025-07-08Not public
Exhibit FBD-T 192025-07-08Not public
Exhibit FBD-T 12025-07-08Not public
Exhibit FBD-T 492025-07-08Not public
Exhibit FBD-T 252025-07-08Not public
Exhibit FBD-T 332025-07-08Not public
Exhibit FBD-T 612025-07-08Not public
Exhibit FBD-T 672025-07-08Not public
Exhibit FBD-T 42025-07-08Not public
Exhibit FBD-T 162025-07-08Not public
Exhibit FBD-T 572025-07-08Not public
Exhibit FBD-T 602025-07-08Not public
Exhibit FBD-T 112025-07-08Not public
Exhibit FBD-T 282025-07-08Not public
Exhibit FBD-T 632025-07-08Not public
Exhibit FBD-T 532025-07-08Not public
Exhibit FBD-T 552025-07-08Not public
Exhibit FBD-T 302025-07-08Not public
Exhibit FBD-T 452025-07-08Not public
Exhibit FBD-T 172025-07-08Not public
EP 767 - Moderna Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Exhibit FBD-T 132025-07-08Not public
Exhibit FBD-T 142025-07-08Not public
Exhibit FBD-T 52025-07-08Not public